Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02209532
What this trial is testing

A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

Who this might be right for
Endometrial CancerUterine CancerCervical Cancer
Novadaq Technologies ULC, now a part of Stryker 180
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Early research (Phase 1)Ended earlyNCT02189174
What this trial is testing

Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Tumor
Novartis Pharmaceuticals 31
Not applicableUnknownNCT03553589
What this trial is testing

Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Andrea Romano 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT01068249
What this trial is testing

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01580696
What this trial is testing

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CancerEndometrial CancerFallopian Cancer+1 more
COL George Peoples, MD, FACS 51
Testing effectiveness (Phase 2)Ended earlyNCT02002689
What this trial is testing

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Who this might be right for
PTCH1 or SMO Activated Solid and Hematologic Tumors
Novartis Pharmaceuticals 10
Not applicableLooking for participantsNCT07544680
What this trial is testing

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Who this might be right for
Abnormal Uterine Bleeding (AUB)Endometrial CancerAtypical Endometrial Hyperplasia+2 more
Exact Sciences Corporation 4,200
Not applicableStudy completedNCT05243823
What this trial is testing

Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

Who this might be right for
Postmenopausal Vaginal Atrophy
Novo Nordisk A/S 500,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT01244789
What this trial is testing

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
Danish Gynecological Cancer Group 244
Not applicableStudy completedNCT03207074
What this trial is testing

Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?

Who this might be right for
Endometrial NeoplasmsEndometrial CancerEndometrial Hyperplasia+1 more
Imperial College London 150
Not applicableLooking for participantsNCT07810920
What this trial is testing

Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine

Who this might be right for
EndometriosisAdenomyosis of UterusLeiomyoma (Uterine Fibroids)+3 more
Semmelweis University 1,600
Very early researchEnded earlyNCT04906382
What this trial is testing

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell Adenocarcinoma+4 more
Floor Backes, MD 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07516210
What this trial is testing

Adaptive Radiotherapy for Safe Hypofractionation

Who this might be right for
CancerEndometrial CancerProstate Cancer+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 264
Testing effectiveness (Phase 2)Looking for participantsNCT05797168
What this trial is testing

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Who this might be right for
Ovarian CancerLung AdenocarcinomaEndometrial Cancer+1 more
AstraZeneca 602
Not applicableLooking for participantsNCT07025213
What this trial is testing

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

Who this might be right for
Endometrial Cancer
National Institute of Cancerología 80
Testing effectiveness (Phase 2)Study completedNCT00032162
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+2 more
AGO Study Group 63
Testing effectiveness (Phase 2)Study completedNCT00027690
What this trial is testing

Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus Carcinoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT03276013
What this trial is testing

Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Vall d'Hebron Institute of Oncology 48
Not applicableUnknownNCT05310318
What this trial is testing

Prognosis of Low-grade Endometrial Stromal Sarcoma

Who this might be right for
Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)Fertility-sparing SurgerySurvival Outcomes+4 more
Lei Li 1,000
Next Page